Doctors Without Borders warned Tuesday that rising intellectual property rights are blocking the generic production of newer drugs to treat HIV and are keeping them out of reach for developing countries  The medical aid group said at an international AIDS meeting in Kuala Lumpur Malaysia that prices of older drugs long used to treat patients have fallen sharply as India and other countries make generics But newer drugs that are more effective against the AIDS virus are too expensive costing up to  times more   Its good news that the price of key HIV drugs continues to fall as more generic companies compete for the market but the newer medicines are still priced far too high said Jennifer Cohn medical director for Doctors Without Borders access campaign We need the newer treatments for people that have exhausted all other options but patents keep them priced beyond reach   Patients can be treated with a combination of three or four older drugs but those who develop resistance to them need the expensive newer medicines   According to Doctors Without Borders the governments of Thailand and Jamaica pay  and  respectively a year per patient for the new drug darunavir alone Paraguay pays  for etravirine while Armenia pays  for raltegravir In comparison a cocktail of older generic drugs costs as little as  per person a year   Doctors Without Borders urged the United States and  other countries negotiating a TransPacific Partnership not to sign the freetrade pact It warned that the pact will increase intellectual property rights across Asia and the Americas expanding monopoly protection for medicines and threatening cheap access to drugs   It said the World Health Organizations new guidelines which recommend earlier treatment for adults means that an additional  million people in developing countries will now be eligible for treatment At the moment only about  percent of those who need the drugs are getting them   Scaling up HIV treatment and sustaining people on treatment for life will depend on bringing the price of newer drugs down said Arax Bozadijan an HIV pharmacist for Doctors Without Borders   The TransPacific pact countries account for nearly  percent of global GDP and about a third of world trade and any agreement could significantly impact prices President Barack Obamas administration has said it hopes to wrap up talks by the end of the year 